Brazil’s health regulator scraps Bharat Biotech’s EUA application of Covaxin

The move comes after Anvisa was informed by Bharat Biotech that it’s Brazilian partner-Necessidade no longer has authorization to represent them in Brazil.

WordPress › Error

There has been a critical error on this website.

Learn more about troubleshooting WordPress.